These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29468926)

  • 21. Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer.
    Yassin AE; Anwer MK; Mowafy HA; El-Bagory IM; Bayomi MA; Alsarra IA
    Int J Med Sci; 2010 Nov; 7(6):398-408. PubMed ID: 21103076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation.
    Gupta PN; Mahor S; Rawat A; Khatri K; Goyal A; Vyas SP
    Int J Pharm; 2006 Aug; 318(1-2):163-73. PubMed ID: 16621367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(vinyl alcohol)-coated chitosan microparticles act as an effective oral vaccine delivery system for hepatitis B vaccine in rat model.
    Shrestha B; Rath JP
    IET Nanobiotechnol; 2014 Dec; 8(4):201-7. PubMed ID: 25429498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and in vitro evaluation of polymeric enteric nanoparticles as dermal carriers with pH-dependent targeting potential.
    Sahle FF; Balzus B; Gerecke C; Kleuser B; Bodmeier R
    Eur J Pharm Sci; 2016 Sep; 92():98-109. PubMed ID: 27393341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
    Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X
    Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eudragit
    El-Maghawry E; Tadros MI; Elkheshen SA; Abd-Elbary A
    Int J Nanomedicine; 2020; 15():3965-3980. PubMed ID: 32606658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
    Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
    Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery.
    Ma Y; Fuchs AV; Boase NR; Rolfe BE; Coombes AG; Thurecht KJ
    Eur J Pharm Biopharm; 2015 Aug; 94():393-403. PubMed ID: 26117186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
    Singh G; Pai RS
    J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
    Pawar D; Mangal S; Goswami R; Jaganathan KS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin immobilized liposomal constructs for transmucosal vaccination through nasal route.
    Tiwari B; Agarwal A; Kharya AK; Lariya N; Saraogi G; Agrawal H; Agrawal GP
    J Liposome Res; 2011 Sep; 21(3):181-93. PubMed ID: 20626315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance.
    Jahangir MA; Khan R; Sarim Imam S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):66-78. PubMed ID: 29226729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation design space for stable, pH sensitive crystalline nifedipine nanoparticles.
    Jog R; Unachukwu K; Burgess DJ
    Int J Pharm; 2016 Nov; 514(1):81-92. PubMed ID: 27863686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.
    Shukla A; Katare OP; Singh B; Vyas SP
    Int J Pharm; 2010 Jan; 385(1-2):47-52. PubMed ID: 19835938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro release of acyclovir loaded Eudragit RLPO(®) nanoparticles for sustained drug delivery.
    Gandhi A; Jana S; Sen KK
    Int J Biol Macromol; 2014 Jun; 67():478-82. PubMed ID: 24755259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
    Pawar D; Jaganathan KS
    Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustainable Stabilizer-Free Nanoparticle Formulations of Valsartan Using Eudragit
    Hajba-Horváth E; Fodor-Kardos A; Shah N; Wacker MG; Feczkó T
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres.
    Momoh MA; Kenechukwu FC; Nnamani PO; Umetiti JC
    Drug Deliv; 2015; 22(6):837-48. PubMed ID: 24670092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketoprofen-loaded Eudragit electrospun nanofibers for the treatment of oral mucositis.
    Reda RI; Wen MM; El-Kamel AH
    Int J Nanomedicine; 2017; 12():2335-2351. PubMed ID: 28392691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.